Shared on 05 Sep 25
CNS Pipeline And Global Expansion Will Unlock Future Opportunities
With both future P/E and consensus revenue growth forecasts essentially unchanged, there has been no meaningful revision to H. Lundbeck's analyst price target, which remains at DKK48.18.
Shared on 01 May 25
Fair value Decreased 6.90%CNS Pipeline And Global Expansion Will Unlock Future Opportunities
Shared on 23 Apr 25
Vyepti's Expansion And anti-PACAP Developments Will Strengthen Future Outlook
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on 17 Apr 25
Vyepti's Expansion And anti-PACAP Developments Will Strengthen Future Outlook
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on 09 Apr 25
Fair value Increased 9.04%Vyepti's Expansion And anti-PACAP Developments Will Strengthen Future Outlook
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on 02 Apr 25
Fair value Decreased 7.96%Vyepti's Expansion And anti-PACAP Developments Will Strengthen Future Outlook
Shared on 26 Mar 25
Vyepti's Expansion And anti-PACAP Developments Will Strengthen Future Outlook
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on 19 Mar 25
Fair value Decreased 0.17%Vyepti's Expansion And anti-PACAP Developments Will Strengthen Future Outlook
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on 12 Mar 25
Fair value Increased 7.71%Vyepti's Expansion And anti-PACAP Developments Will Strengthen Future Outlook
AnalystConsensusTarget made no meaningful changes to valuation assumptions.